Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00421902 · ClinicalTrials.gov registry record · NA

Acupuncture Treatment for Hot Flashes Study

A NA study of Prostate Cancer, sponsored by New York Presbyterian Brooklyn Methodist Hospital.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT00421902: Completed NA study of Prostate Cancer, sponsored by New York Presbyterian Brooklyn Methodist Hospital.

NCT00421902 is a NA study of Prostate Cancer that has completed, run by New York Presbyterian Brooklyn Methodist Hospital. The registered enrollment target is 50 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00421902, a NA study of Prostate Cancer, has completed, sponsored by New York Presbyterian Brooklyn Methodist Hospital.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

Patients with prostate cancer who are / were treated with hormonal treatment and developed hot flashes as a side effect are offered Acupuncture as an investigational intervention. The treatment is performed twice a week for four weeks, then once a week for the following six weeks

Primary Outcome

A Questionnaire was given to the patients to determine the relief of hot flashes

Conditions Studied

Interventions

  • PROCEDURE Acupuncture

Study Locations (1)

New York

  • NYP- Brooklyn Methodist Hospital - Brooklyn

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2006-01
Est. Completion 2012-06
Phase NA

What the finished NCT00421902 record still lists

NCT00421902 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (92% lower).

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Acupuncture is the first listed.

NCT00421902 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT00421902 about?

NCT00421902 is a clinical study titled "Acupuncture Treatment for Hot Flashes Study". Patients with prostate cancer who are / were treated with hormonal treatment and developed hot flashes as a side effect are offered Acupuncture as an investigational intervention. The treatment is performed twice a week for four weeks, then once a week for the following six weeks

What is the current status of trial NCT00421902?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2006-01. Estimated completion is 2012-06.

What conditions does trial NCT00421902 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT00421902?

The interventions under investigation include: Acupuncture (PROCEDURE).

Who is sponsoring clinical trial NCT00421902?

This trial is sponsored by New York Presbyterian Brooklyn Methodist Hospital, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00421902 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00421902's enrollment target sits among peer trials

50 469th of 735 higher than 247 of 735 other Prostate Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00421902, the US trial registry maintained by the National Library of Medicine. NCT00421902 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.